PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for November 8, 2005 Subscribe to this News Feed    
 

MediMeme Launches of IntelliMeme – Competitive Intelligence Single Source Database

MediMeme, LLC announced launch of its initial pharmaceutical marketing intelligence product, IntelliMeme™ - Competitive Intelligence, the only single source database providing access to detailed drug information from major medical conferences around the world with competitive dollars spent by exhibitors and sponsors – in real time.

New York, NY (PRWEB) November 8, 2005 -- MediMeme, LLC announced launch of its initial pharmaceutical marketing intelligence product, IntelliMeme™ - Competitive Intelligence, the only single source database providing access to detailed drug information from major medical conferences around the world with competitive dollars spent by exhibitors and sponsors – in real time.

Company CEO, Mahesh Naithani, states that while the information is syndicated in one sense, it can be customized for each client to focus only on information of interest to them by filtering the data based on their specification of drug/s, disease, indication, and treatment criteria.

The company was founded earlier this year by Mr. Naithani, a pioneer in syndicated medical marketing studies, and former Chairman of Healthcare Communications, Inc. (now PERQ/HCI, a VNU company) and Reliance Medical Information. Dennis Turner, founder and former Chairman of Walsh International, is MediMeme, LLC Chairman of the Board. They are joined in managing the firm by Thomas Moore, former President of Procter & Gamble’s World Wide Health Care Group.

Mr. Naithani explains that MediMeme, LLC is a unique health care information services company because it focuses on medical conferences as the increasingly important place for medical professionals and the healthcare industry to effectively meet and interact, a trend driven by increasing cost and decreasing effectiveness in traditional forms of communication with physicians. He points out the importance of the role medical societies play, providing the forums for this to happen through their conferences.

He further explains that by drawing competitive intelligence from the more important of the 10,000 medical conferences around the world, MediMeme, LLC can move client’s knowledge base forward by a year, or more, because medical conference meetings are the first place break-through medicine is discussed, before it surfaces in other forms and venues. It is also the place to track the emergence of thought leaders and how medical opinions are being influenced in real time, with clear objective data not available from any other single source.

“Supplementing medical conference data with dollars spent analysis at these events, and with the daily flow of news and information about specific drugs, diseases, indications and treatments from other sources, as MediMeme, LLC does, creates the most up-to-date, comprehensive source of clinical and medical marketing intelligence information available anywhere,” he states.

Media Contact:
Yan Barshay
212-725-5992
http://www.medimeme.com

# # #

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
Email this story to a colleague
CONTACT INFORMATION
Yan Barshay
Medimeme, LLC
212-725-5992
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.